We have been serving the pharmaceutical industry, and more generally the scientific research community, for more than 30 years.
Every member of our team is an experienced medical writer with a PhD, and all are native English or French speakers with bilingual proficiency in French and English. We design and write medical marketing documents intended for the scientific community, healthcare professionals or the general public, as well as all the regulatory and clinical documentation required at the various stages of drug development, regardless of the therapeutic area. We also provide an editorial assistance service to support you in the publication of your research: from the correction of your article to its submission, and the drafting of responses to reviewers.
We work accurately and efficiently to meet your deadlines, while our compliance with international standards (CONSORT, ICH, etc.), systematic proofreading between medical writers, and attention to detail guarantee that your documents will be of the highest quality. Our adaptability and responsiveness lead us to develop privileged and ongoing relationships with our clients.
Each project is unique, and our team at Santé Active Edition-Synergy Pharm are on hand to adapt and respond to your requirements. Do not hesitate to contact us to discuss your needs, we are looking forward to assisting you with your projects!
Seborrheic dermatitis (SD) affects 1–5% of adults worldwide. While not contagious or related to diet, SD can be aggravated by illness, stress, tiredness, changes of season, and an overall deterioration of health status. This chronic inflammatory skin disorder can considerably impact quality of life and self-esteem, particularly due to the physical discomfort associated with persistent itching.
Read more
This year marks the fifth anniversary of Newborn Screening (NBS) day, an event celebrated annually on June 28 to coincide with the birthday of Robert Guthrie, the American doctor who developed the first NBS test.
The International Neonatal Screening Day (INSD) campaign is organized by Screen4Rare, a multi-stakeholder platform launched by several partners, including the International Society for Neonatal Screening (ISNS), the International Patient Organisation for Primary Immunodeficiencies (IPOPI) and the European Society for Immunodeficiencies (ESID).
Read more